Expression of CD34 and bcl-2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast

Histopathology

Volumn 38, Issue 1, 2001, Pages 62-67

  Moore, T ^a   Lee, A H S ^a,b,c  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Bcl 2; Breast; Carcinoma; CD34; Fibroadenoma; Phyllodes tumour

Indexed keywords

CD34 ANTIGEN; PROTEIN BCL 2;

ADENOSQUAMOUS CARCINOMA; ARTICLE; BREAST CARCINOGENESIS; BREAST FIBROADENOMA; BREAST TUMOR; CONTROLLED STUDY; CYSTOSARCOMA PHYLLOIDES; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; HAMARTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MESENCHYME CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINDLE CELL CARCINOMA;

ANTIGENS, CD34; BREAST NEOPLASMS; CARCINOMA; FIBROADENOMA; HUMANS; IMMUNOHISTOCHEMISTRY; PHYLLODES TUMOR; PROTO-ONCOGENE PROTEINS C-BCL-2;

MYOIDEA; PHYLLODES;

EID: 0035156265     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2001.01053.x     Document Type: Article

References (36)

1. bcl-2 expression in pleural and extrapleural solitary fibrous tumours
2. Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract
3. Expression of the CD34 gene in vascular endothelial cells
4. Rouse RV. CD34. A review
5. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
6. Cloning of the chromosome breakpoint of neoplastic B ceils with the t(14:18) chromosome translocation
7. Cloning the chromosomal breakpoint of t(14:18) human lymphomas: Clustering around JH on chromosome 14 and near transcriptional unit on 18
8. Expression of the bcl-2 oncogene protein is not specific for the 14:18 chromosomal translocation
9. bcl2 protein is topographically restricted in tissues charcterised by apoptotic cell death
10. Bcl-2 breathes life into embryogenesis
11. Phyllodes tumours of the breast: A clinicopathological review of thirty-two cases
12. Immunostaining methods for frozen and paraffin sections
13. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections
14. Ultrastructural and immunohistochemical observations on intralobular fibroblasts of human breast, with observations on the CD34 antigen
15. Comparison of four endothelial markers for assessing angiogenesis in carcinoma of the breast
16. The human progenitor cell antigen (CD34) is localised on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma
17. CD34 expression in stromal tumours of the gastrointestinal tract and in mesenteric fibromatoses
18. Immunophenotypic features of uterine stromal cells. CD34 expression in endocervical stroma
19. Vascular density does not predict future metastatic disease in clinical stage 1 non-seminomatous germ cell tumours of the testis
20. Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34
21. Fibroid polyps of intestinal tract are inflammatory-reactive proliferations of CD34-positive perivascular cells
22. Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages
23. Myofibroblastoma and solitary fibrous tumor of the breast: Histopathological and immunohistochemical comparative study
24. Muscular hamartoma of the breast. Case report and review of the literature
25. Mammary hamartoma - A review of 35 cases
26. Pseudoangiomatous stromal hyperplasia (PASH). A mammary stromal tumour with myofibroblastic differentiation
27. Pseudoangiomatous hyperplasia of mammary stroma associated with gynaecomastia
28. Fibrosarcomatous ('high-grade') dermatofibrosarcoma protuberans. Clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance
29. Solitary fibrous tumour: Significance of p53 and CD34 immunoreactivity in its malignant transformation
30. Malignant phyllodes tumours of the breast display increased stromal p53 expression
31. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia
32. Assessment of angiogenesis in breast carcinoma: An important factor in prognosis?
33. Endothelial area as a prognostic indicator for invasive breast carcinoma
34. Expression of BCL-2 in the developing human fetal and infant breast
35. Immunohistochemical profile of phyllodes tumors of the breast
36. Altered expression of p53 and its regulated proteins in phyllodes tumours of the breast